Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026Business Wire • 04/17/26
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak ManagementBusiness Wire • 04/17/26
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XRBusiness Wire • 02/25/26
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic ApplicationsBusiness Wire • 02/24/26
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological SpectrumBusiness Wire • 02/23/26
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease BiologyBusiness Wire • 02/23/26
Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the StockZacks Investment Research • 02/18/26
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QCBusiness Wire • 02/09/26
Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI OrchestrationBusiness Wire • 02/09/26
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and WebcastBusiness Wire • 02/05/26
Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRIBusiness Wire • 01/09/26